Bio­gen fires staffer who fled to Chi­na af­ter she was in­fect­ed in the biotech’s coro­n­avirus out­break

6 years ago
Coronavirus

Drug­mak­er re­thinks its de­ci­sion to dou­ble price of a gener­ic af­ter Trump calls it a coro­n­avirus life­saver — re­ports

6 years ago
Coronavirus

Bio­gen sues com­pa­ny al­leged­ly sell­ing ad­u­canum­ab copy­cat; J&J takes on No­var­tis' MS fran­chise

6 years ago
News Briefing

A trop­i­cal dis­ease doc­tor turns his sights on the coro­n­avirus

6 years ago
R&D
Coronavirus

Pfiz­er's JAK1 chal­lenger to Dupix­ent shines in an­oth­er PhI­II, but safe­ty is­sues still cast a shad­ow

6 years ago
R&D

FDA un­veils guid­ance for Covid-19 tri­als

6 years ago
FDA+
Coronavirus

Do­ing deals in a time of coro­n­avirus: Biotech CEO Bill Haney says 'y­ou fo­cus on the things that make a dif­fer­ence'

6 years ago
People
Deals

Bio­gen flags de­lays on Spin­raza treat­ments as hos­pi­tals shift fo­cus and re­sources to pan­dem­ic pa­tients

6 years ago
R&D

GSK qui­et­ly re­veals just how much cash they used to buy a chunk of the Bay Area's buzzi­est start­up

6 years ago
People
Deals

New da­ta from ran­dom­ized tri­al dent HIV drug strat­e­gy against Covid-19

6 years ago
R&D
Coronavirus

Covid-19 roundup: Fred Hutch cuts down fur­ther on lab work, Roche joins Re­gen­eron and Sanofi in IL-6 tri­als, Chi­na ...

6 years ago
Coronavirus

A Japan­ese flu drug gets up­beat re­views in Chi­na for blunt­ing the im­pact of Covid-19 — and that is bol­ster­ing ...

6 years ago
R&D
China

Bay­er fires em­ploy­ee who was spot­ted break­ing quar­an­tine in Chi­na

6 years ago
China
Pharma

In­sil­i­co inks an­oth­er deal with Sino Bio­phar­ma unit; Ra­maswamy's Data­vant to in­vest in the "pa­tient jour­ney"

6 years ago
News Briefing

Sage plots come­back plan for its ex­per­i­men­tal oral an­ti­de­pres­sant

6 years ago
R&D

Covid-19 roundup: Trump back­tracks on NIH/CDC fund­ing, No­var­tis launch­es $20M fund, FDA and ICER can­cel­la­tions

6 years ago
R&D
Coronavirus

Bris­tol My­ers CEO Caforio hires a top in­vest­ment banker from Bar­clays for his next BD/strat­e­gy chief

6 years ago
People

TCR play­er Im­mat­ics com­bines with Per­cep­tive’s blank check op­er­a­tor, scoop­ing $252M and gain­ing a list­ing on Nas­daq

6 years ago
Deals
R&D

Covid-19 could throw fi­nal hur­dle in­to Ab­b­Vie and Al­ler­gan’s mas­sive merg­er

6 years ago
Deals
R&D

As Covid-19 R&D goes in­to over­drive, nuts-and-bolts bio­phar­ma re­search is hit­ting the skids. How bad is it?

6 years ago
R&D
Coronavirus

For­mer Shire ex­ecs set up shop to take a shot at 'un­der the radar' can­cer tar­get

6 years ago
Financing
Startups

Con­tract man­u­fac­tur­er: FDA has halt­ed do­mes­tic phar­ma in­spec­tions

6 years ago
FDA+
Coronavirus

The big C: The deal­mak­ers, dol­lars and dis­eases that have trans­formed the Chi­nese bio­phar­ma mar­ket

6 years ago
Financing
Deals

UK takes tougher stance to com­bat coro­n­avirus, as pre­vi­ous ap­proach risks hun­dreds of thou­sands of lives — study

6 years ago
Coronavirus
First page Previous page 859860861862863864865 Next page Last page
A service from the Financial Times